In this episode Dr. McNamara discusses the side effects of Lowering Co-Enzyme Q10 with the usage of Cholesterol-Lowering Statin Drugs.
- Chapter 20: The Effects of Lowering Co-Enzyme Q10 with Statin Drugs
- Chapter 21: Statin Drugs May Cause Muscle Weakness & Destruction
- Chapter 22: Statin Drugs May Cause Heart Disease, Heart Failure, and Death
- Chapter 23: Statin Drugs May Damage the Liver
- Chapter 24: Stain Drugs May Damage the Brain and Nerves
Chapter Excerpts
Since all organs and all cells rely on the ubiquitous Co-Q10, the depletion of it by statin drugs causes problems everywhere in the body.
Additionally, Co-Q10 was shown to increase blood levels of vitamin E and significantly increase the levels of protective HDL. As low HDL is a major risk factor for heart disease, increasing it is a definite benefit. Statin drugs were shown not to provide any benefit beyond supplementing with Co-Q10.
Co-Q10 depletion will become more and more of a problem as the pharmaceutical industry encourages doctors to lower cholesterol levels in their patients even more than ever. Is it possible that we are going to see an epidemic of congestive heart disease and cardiomyopathy, as well as cancer, among those taking cholesterol-lowering statin drugs?
So much denial exists within the cholesterol conspiracy that many doctors will not associate common side-effect symptoms and resultant diseases with the use of a statin drug… physicians and patients need to be educated regarding the symptoms of a statin drug are.
Chapter References
- 35: Cullen D, Bates D, Small S, et al. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Joint Commission Journal on Quality Improvement, Oct. 1995 21(10):541-548.
- 37: Singh R, Neki N, Kartikey K, et al. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem. 2003 Apr; 246(1-2):75-82.
- 38: Langsjoen P, Langsjoen A. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. Biofactors. 2003 18(1-4):101-111.
- 39: Mortensen S. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone). Clin Investig 1993 71(8 Supp):S116-123 and S140-144.
- 40: Langsjoen P, Folkers K, Lyson K, et al. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy. Int J Tissue React 1990 12:163-168.
- 22: Schwartz G, Olsson A, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA 2001 285:1711-1718.
- 41: Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002 May 14; 58(9):1333-1337.
Podcast: Play in new window | Download